SCHEMBL4196477

SCHEMBL4196477

Cc1c(O)c(F)c2c(c(-c3ccc(O)c(Cl)c3)nc3[nH]ncc32)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.39
▸ JAK1 P23458 1/20 0.39
▸ TYK2 P29597 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ PIK3CA P42336 2/20 0.37
▸ FGFR1 P11362 2/20 0.35
▸ FGFR2 P21802 1/20 0.35
▸ ADORA2A P29274 2/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ GYS1 P13807 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ TP53 P04637 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAOB P27338 1/20 0.34
▸ SGK1 O00141 3/20 0.33
▸ ESR1 P03372 2/20 0.33
▸ ESR2 Q92731 2/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ GSK3A P49840 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4196409 0.87 JAK2 (0.36) JAK2JAK1TYK2JAK3PIK3CA
SCHEMBL4195967 0.86 JAK2 (0.35) JAK2JAK1TYK2JAK3FGFR1
SCHEMBL4197625 0.84 JAK2 (0.36) JAK2JAK1TYK2JAK3PIK3CA
SCHEMBL4198966 0.83 JAK2 (0.35) JAK2JAK1TYK2JAK3TP53
SCHEMBL4201049 0.83 TGFBR1 (0.32) TP53LMNA
SCHEMBL4197075 0.79 JAK2 (0.35) JAK2JAK1TYK2JAK3FGFR1
Hydrochloric Acid SCHEMBL4206701 0.78 NT5E (0.32) —
SCHEMBL4196482 0.78 JAK2 (0.33) JAK2JAK1TYK2JAK3ADORA2A
SCHEMBL4194239 0.77 SGK1 (0.32) JAK2JAK1TYK2JAK3ADORA2A
SCHEMBL4189785 0.77 JAK2 (0.34) JAK2JAK1TYK2JAK3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648455-A4 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2009-03-04 — — EP disclosed
EP-1648455-A2 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2006-04-26 — — EP disclosed
WO-2005009389-A2 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-02-03 — — WO disclosed
Send feedback